Developmental Epidemiology of Pediatric Anxiety Disorders.

This review summarizes the developmental epidemiology of childhood and adolescent anxiety disorders. It discusses the coronavirus disease of 2019 (COVID-19) pandemic, sex differences, longitudinal course, and stability of anxiety disorders in addition to recurrence and remission. The trajectory of anxiety disorders-whether homotypic (ie, the same anxiety disorder persists over time) or heterotypic (ie, an anxiety disorder shifts to a different diagnosis over time) is discussed with regard to social, generalized, and separation anxiety disorders as well as specific phobia, and panic disorder. Finally, strategies for early recognition, prevention, and treatment of disorders are discussed.
Competing Interests: Disclosures Dr J.R. Strawn has received research support from the Yung Family Foundation, the National Institutes of Health (NIMH/NIEHS/NICHD), the National Center for Advancing Translational Sciences, United States, the Patient-Centered Outcomes Research Institute, United States and Abbvie, United States. He has received material support from Myriad Health and royalties from three texts (Springer). Dr J.R. Strawn serves as an author for UpToDate and an Associate Editor for Current Psychiatry and has provided consultation to the FDA, Cereval, and IntraCellular Therapeutics. Views expressed within this article represent those of the authors and are not intended to represent the position of NIMH, United States, the National Institutes of Health, United States, or the Department of Health and Human Services.
(Copyright © 2023 Elsevier Inc. All rights reserved.)